SYNTHESIS OF 1,4-DIHYDROPIRIDINE DERIVATIVES IN MICROWAVE FLOW REACTOR
dc.contributor.author | Khrustaleva, Anastassiya | |
dc.contributor.author | Khrustalev, Dmitriy | |
dc.contributor.author | Yedrissov, Azamat | |
dc.contributor.author | Mustafin, Marlen | |
dc.date.accessioned | 2022-09-12T10:43:16Z | |
dc.date.available | 2022-09-12T10:43:16Z | |
dc.date.issued | 2022-08 | |
dc.description.abstract | 1,4-Dihydropyridine derivatives (e.g. Nimodipine, Nifedipine, Nitrendipine), which belong to the group of calcium channel blockers, serve as effective drugs in the treatment of cardiovascular diseases. According to the World Health Organization (WHO), this disease class ranks first in terms of the number of deaths worldwide. Considering the unfavorable statistics of mortality from cardiovascular diseases, which is about 17 million people per year, the development of unique, cost- effective methods of obtaining 1,4-dihydropyridine derivatives is an urgent task. | en_US |
dc.identifier.citation | Khrustaleva, A. Khrustalev, D. Yedrissov, A. Mustafin, M. (2022). Synthesis of 1,4-dihydropiridine derivatives in microwave flow reactor. National Laboratory Astana | en_US |
dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/6668 | |
dc.language.iso | en | en_US |
dc.publisher | National Laboratory Astana | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
dc.subject | Type of access: Embargo | en_US |
dc.subject | 1,4-Dihydropyridine derivatives | en_US |
dc.title | SYNTHESIS OF 1,4-DIHYDROPIRIDINE DERIVATIVES IN MICROWAVE FLOW REACTOR | en_US |
dc.type | Abstract | en_US |
workflow.import.source | science |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Synthesis of 1,4-dihydropiridine derivatives in microwave flow reactor.pdf
- Size:
- 41.18 KB
- Format:
- Adobe Portable Document Format
- Description:
- abstract
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 6.28 KB
- Format:
- Item-specific license agreed upon to submission
- Description: